Coronary based atherosclerosis is the largest killer of men and women in the United States. Athera Medical intends to become the leader in providing solutions for detection and treatment of atherosclerosis disease by developing catheter-based systems for detection of atherosclerotic lesions and delivery of a therapeutic to those sites to inhibit their deterioration. The company also aims to become a leader in stent placement optimization and measuring the lipid-lowering potential of drug candidates. The company aims to compete globally by providing a cost-effective solution that demonstrably enhances physician and hospital profitability and reduces healthcare expenditures.
How TVL Helped: TVL helped Athera Medical determine which physicians are most likely to use its imaging technology, as well as research potential IP conflicts.